170 related articles for article (PubMed ID: 9209791)
1. Elevated sulfatide excretion in compound heterozygotes of metachromatic leukodystrophy and ASA-pseudodeficiency allele.
Lugowska A; Tylki-Szymańska A; Berger J; Molzer B
Clin Biochem; 1997 Jun; 30(4):325-31. PubMed ID: 9209791
[TBL] [Abstract][Full Text] [Related]
2. Elevated sulfatide excretion in heterozygotes of metachromatic leukodystrophy: dependence on reduction of arylsulfatase A activity.
Molzer B; Sundt-Heller R; Kainz-Korschinsky M; Zobel M
Am J Med Genet; 1992 Nov; 44(4):523-6. PubMed ID: 1359786
[TBL] [Abstract][Full Text] [Related]
3. Disease-causing mutations in cis with the common arylsulfatase A pseudodeficiency allele compound the difficulties in accurately identifying patients and carriers of metachromatic leukodystrophy.
Rafi MA; Coppola S; Liu SL; Rao HZ; Wenger DA
Mol Genet Metab; 2003 Jun; 79(2):83-90. PubMed ID: 12809637
[TBL] [Abstract][Full Text] [Related]
4. Investigations of micro-organic brain damage (MOBD) in heterozygotes of metachromatic leukodystrophy.
Tylki-Szymańska A; Ługowska A; Chmielik J; Kotowicz J; Jakubowska-Winecka A; Zobel M; Berger J; Molzer B
Am J Med Genet; 2002 Jul; 110(4):315-9. PubMed ID: 12116203
[TBL] [Abstract][Full Text] [Related]
5. Pseudodeficiency of arylsulfatase A: a counseling dilemma.
Baldinger S; Pierpont ME; Wenger DA
Clin Genet; 1987 Feb; 31(2):70-6. PubMed ID: 2881636
[TBL] [Abstract][Full Text] [Related]
6. Compound heterozygosity for metachromatic leukodystrophy and arylsulfatase A pseudodeficiency alleles is not associated with progressive neurological disease.
Penzien JM; Kappler J; Herschkowitz N; Schuknecht B; Leinekugel P; Propping P; Tønnesen T; Lou H; Moser H; Zierz S
Am J Hum Genet; 1993 Mar; 52(3):557-64. PubMed ID: 8095368
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and Genetic Analysis of Seven Korean Individuals With Suspected Metachromatic Leukodystrophy.
Han M; Jun SH; Lee YJ; Eun BL; Lee SJ; Seong MW; Park SS; Song SH; Park HD; Song J
Ann Lab Med; 2015 Jul; 35(4):458-62. PubMed ID: 26131420
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of metachromatic leukodystrophy.
Gieselmann V; Polten A; Kreysing J; Kappler J; Fluharty A; von Figura K
Dev Neurosci; 1991; 13(4-5):222-7. PubMed ID: 1687778
[TBL] [Abstract][Full Text] [Related]
9. An assay for the rapid detection of the arylsulfatase A pseudodeficiency allele facilitates diagnosis and genetic counseling for metachromatic leukodystrophy.
Gieselmann V
Hum Genet; 1991 Jan; 86(3):251-5. PubMed ID: 1671769
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of arylsulfatase A pseudodeficiency allele in metachromatic leukodystrophy patients from Poland.
Lugowska A; Czartoryska B; Tylki-Szymańska A; Bisko M; Zimowski JG; Berger J; Molzer B
Eur Neurol; 2000; 44(2):104-7. PubMed ID: 10965162
[TBL] [Abstract][Full Text] [Related]
11. Urine sulfatides and the diagnosis of metachromatic leukodystrophy.
Natowicz MR; Prence EM; Chaturvedi P; Newburg DS
Clin Chem; 1996 Feb; 42(2):232-8. PubMed ID: 8595716
[TBL] [Abstract][Full Text] [Related]
12. Metachromatic leukodystrophy and pseudoarylsulfatase A deficiency in a Danish family.
Tønnesen T; Bro PV; Brøndum Nielsen K; Lykkelund C
Acta Paediatr Scand; 1983 Mar; 72(2):175-8. PubMed ID: 6132516
[TBL] [Abstract][Full Text] [Related]
13. Genotype-phenotype relationship in various degrees of arylsulfatase A deficiency.
Kappler J; Leinekugel P; Conzelmann E; Kleijer WJ; Kohlschütter A; Tønnesen T; Rochel M; Freycon F; Propping P
Hum Genet; 1991 Mar; 86(5):463-70. PubMed ID: 1673113
[TBL] [Abstract][Full Text] [Related]
14. Arylsulfatase A pseudodeficiency--incidence in Poland.
Czartoryska B; Zimowski JG; Bisko M; Górska D
Eur J Hum Genet; 1996; 4(5):301-3. PubMed ID: 8946177
[TBL] [Abstract][Full Text] [Related]
15. Probable metachromatic leukodystrophy/pseudodeficiency compound heterozygote at the arylsulfatase A locus with neurological and psychiatric symptomatology.
Hohenschutz C; Friedl W; Schlör KH; Waheed A; Conzelmann E; Sandhoff K; Propping P
Am J Med Genet; 1988 Sep; 31(1):169-75. PubMed ID: 2906225
[TBL] [Abstract][Full Text] [Related]
16. Arylsulfatase A in pseudodeficiency.
Herz B; Bach G
Hum Genet; 1984; 66(2-3):147-50. PubMed ID: 6143719
[TBL] [Abstract][Full Text] [Related]
17. HPLC analysis of urinary sulfatide: an aid in the diagnosis of metachromatic leukodystrophy.
Strasberg PM; Warren I; Skomorowski MA; Lowden JA
Clin Biochem; 1985 Apr; 18(2):92-7. PubMed ID: 2861921
[TBL] [Abstract][Full Text] [Related]
18. Pseudodeficiency of arylsulphatase A: strategy for clarification of genotype in families of subjects with low ASA activity and neurological symptoms.
Leistner S; Young E; Meaney C; Winchester B
J Inherit Metab Dis; 1995; 18(6):710-6. PubMed ID: 8750609
[TBL] [Abstract][Full Text] [Related]
19. Deletion of fatty acid amide hydrolase reduces lyso-sulfatide levels but exacerbates metachromatic leukodystrophy in mice.
Yaghootfam C; Gehrig B; Sylvester M; Gieselmann V; Matzner U
J Biol Chem; 2021 Sep; 297(3):101064. PubMed ID: 34375644
[TBL] [Abstract][Full Text] [Related]
20. Metachromatic leukodystrophy: clinical and enzymatic parameters.
McKhann GM
Neuropediatrics; 1984 Sep; 15 Suppl():4-10. PubMed ID: 6152812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
